Presentation
The Parenteral Drug Association (PDA) has recently published Technical Report No. 82 (TR82) on the topic of Low Endotoxin Recovery (LER), providing both consensus to the science and data behind the analytical issue, as well as to analytical and mitigation strategies.
In this webinar, Kevin Williams and Dr. Christian Faderl from bioMérieux, explain the important implications of TR82 as well as presenting the ENDO-RS® sample preparation technology for demasking endotoxin in affected biologics, as described in Case Study 7 of TR82.
Part I: TR82 Low Endotoxin Recovery - Takeaways
Presenter:
Kevin Williams
Senior Scientist Endotoxin
bioMérieux
Part II: The ENDO-RS® technology and bioMérieux LER services
Presenter:
Dr. Christian Faderl Project
Coordinator LER Services
Hyglos - a bioMérieux company
|